Guang-Ying Hou

Optimal timing of stereotactic radiosurgery with first-line osimertinib in EGFR-mutant non-small cell lung cancer brain metastases: Immediate, early-consolidation and salvage strategies

The optimal timing for integrating stereotactic radiosurgery (SRS) with first-line osimertinib in EGFR-mutant non-small cell lung cancer (NSCLC) with brain metastases (BMs) is undefined. The present study compared outcomes of three distinct SRS timing strategies. In the present dual-center retrospective study, patients...